SHENZHEN, China, Oct. 23 /Xinhua-PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced it will attend the China International Medical Equipment Fair (“CMEF”) at the New International Convention and Exhibition Centre in Chengdu, China from October 24 to 27, 2007.
“We are excited to exhibit our products at this rapidly growing international event,” said Mr. Xu Hang, Mindray’s chairman and co-chief executive officer. “With world-class R&D, our high-quality products have received strong demand from diverse markets around the globe. Consistent with our long-term strategy, we are developing distribution networks and investing in both international offices and top talent to meet the widespread demand for our products.”
Mindray will display its products at the New International Convention & Exposition Centre in Hall 4, booth number B06 from October 24 to 27, 2007. The company will host over 60 international distributors at the CMEF. On October 25, 2007, Mindray executives will lead a hospital tour in Chengdu followed by a distributor banquet.
Domestically, Mindray has over 1,800 distributors and over 800 direct sales and sales support personnel. Internationally, the company leverages more than 1,000 distributors and 250 sales and sales support personnel. Mindray has 29 China-based and 10 international offices, including recently opened offices in Amsterdam, Mexico City, Sao Paulo and Toronto.
About Mindray
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Amsterdam, Boston, Istanbul, London, Mexico City, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit http://www.mindray.com .
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about Mindray’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our registration statement on Form F-1 and other documents filed with the Securities and Exchange Commission. Mindray does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release is as of October 23, 2007, and Mindray undertakes no duty to update such information, except as required under applicable law.
For further information, please contact:
In China:
Investor Relations
Mindray Medical International Limited
Tel: +86-755-2658-2518
Email: IR@mindray.com
Justin Knapp
Ogilvy Public Relations Worldwide, Beijing
Tel: +86-10-8520-6556
Email: Justin.Knapp@ogilvy.com
In U.S.:
Jeremy Bridgman
Ogilvy Public Relations Worldwide, New York
Tel: +1-212-880-5269
